Home Reported Outcomes in PNH: A Mobile App-Based, Prospective, Observational Program to Evaluate Disease Burden and Treatment Patterns in Paroxysmal Nocturnal Hemoglobinuria in the US

Sponsor

Image
novartis--with-alpha.png

Contact Info

Folia Health
research@foliahealth.com
913-553-7913

Start Date: May 31, 2024 End Date: December 31, 2026

Non-therapeutic Study: The purpose of a non-therapeutic study is to increase the understanding of a disease or condition through observation, data collection, or other methods. A non-therapeutic study does not provide treatment or intervention for participants. This type of research contributes to general knowledge that may benefit others in the future by improving treatment or developing new therapies. If you are interested in learning more about your possible participation in this study, please complete the form. Your information will be forwarded directly to the study sponsor.

Purpose

This study aims to capture the full spectrum of symptoms, treatment utilization, and overall Health-Related Quality of Life (HRQoL) experienced by PNH patients.  As a participant, you will track what you're noticing about your health in the Folia Health app once per week for 6 months.  

You will use the Folia Health mobile app to enroll, consent, and complete all study activities.  You'll be asked to track routine treatment, symptoms, changes in treatment plans, and HRQoL using the app. You'll also complete monthly survey check-ins, with the possibility of integrating electronic health record (EHR) and/or claims data.  

There are no medical history or treatment restrictions for this study.  

Patients enrolled in the study will be compensated for participating. 
 

Status
Enrolling
Bone Marrow Disease(s)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Gender
Female
Male
Age Group
18 years and older
Accepts Healthy Volunteers
No
Inclusion Criteria
  1. Aged 18 or older
  2. US-based with a proficient understanding of and ability to read the English language
  3. Any patient with a diagnosis of PNH, regardless of current treatment use.
Exclusion Criteria

Study participants who do not fit all inclusion criteria listed above are unable to participate in this study.

Find Out More:

Disclaimer:

AAMDSIF does not recommend, endorse, or make any representation about the efficacy, appropriateness or suitability of any research study listed on this website. Pharmaceutical company sponsored content is highlighted only to give additional information about the study. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a research study and never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.